Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Severe hepatotoxicity on beginning propylthiouracil therapy

D R Lock1, Z M Sthoeger

  • 1Endocrinology Unit, Kaplan Hospital, Rehovot, Israel.

Journal of Clinical Gastroenterology
|June 1, 1997
PubMed
Summary

Propylthiouracil (PTU) can cause liver damage in Graves' disease patients. Although liver abnormalities may persist for years, complete recovery from PTU-induced hepatotoxicity is possible.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Better outcomes of HIV-1 infection in women compared to men in an Ethiopian cohort.

HIV research & clinical practice·2025
Same author

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.

PloS one·2015
Same author

The Cytology Program in British Columbia: I. An Evaluation of the Effectiveness of Cytology in the Diagnosis of Cancer and its Application to the Detection of Carcinoma of the Cervix.

Canadian Medical Association journal·2010
Same author

A case report of poliomyelitis (bulbar type).

Canadian journal of medical technology·2010
Same author

Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis.

Journal of clinical immunology·2008
Same author

Internal jugular vein thrombosis following mild ovarian hyperstimulation syndrome in women with factor V Leiden mutation.

The American journal of the medical sciences·2006

Area of Science:

  • Hepatology
  • Endocrinology
  • Pharmacology

Background:

  • Graves' disease is an autoimmune disorder treated with antithyroid drugs.
  • Propylthiouracil (PTU) is a common medication used to manage hyperthyroidism in Graves' disease.
  • Drug-induced liver injury is a known, albeit rare, complication of PTU therapy.

Observation:

  • A patient with Graves' disease developed cholestatic hepatotoxicity within one day of initiating PTU treatment.
  • Clinical recovery was observed, but liver enzyme abnormalities persisted for five years post-treatment.
  • Percutaneous liver biopsy and normalization of enzyme levels confirmed the absence of permanent liver damage.

Findings:

  • Prolonged elevation of serum liver enzymes is indicative of PTU-induced hepatotoxicity.

Related Experiment Videos

  • The liver injury in this case was severe and persistent, lasting for five years.
  • Despite the prolonged duration, the liver damage was ultimately reversible.

    • Implications:

    • This case highlights the potential for delayed and prolonged liver enzyme elevation following PTU-induced hepatotoxicity.
    • It underscores the importance of monitoring liver function in patients receiving PTU, even after initial recovery.
    • Complete resolution of PTU-induced liver injury is achievable, emphasizing the need for continued patient follow-up.